Form 4 for ONC BeOne Medicines Ltd.
Accepted 2026-03-13 00:00:00 ET · period of report 2026-03-11 · accession 0001980648-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-13 | 2026-03-11 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $191.64 | +341 | 341 | New | +$65.3K |
| D | 2026-03-13 | 2026-03-11 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $300.00 | -341 | 0 | -100% | -$102.3K |
| DM | 2026-03-13 | 2026-03-11 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $0.00 | -4,433 | 22.5K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2026-03-11 | M | A | 133 | $213.32 | 243 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. |
| 2 | Common | American Depositary Shares | 2026-03-11 | S | D | 341 | $300.00 | 0 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. |
| 3 | Common | American Depositary Shares | 2026-03-11 | M | A | 110 | $194.47 | 110 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. |
| 4 | Common | American Depositary Shares | 2026-03-11 | M | A | 98 | $159.03 | 341 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. |
| 5 | Derivative | Share Option (Right to Buy) | 2026-03-11 | M | D | 1,729 | $0.00 | 86,684 | D | $16.41 · — to 2033-06-14 | 1,729 Ordinary Shares | (F3) The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. (F5) These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. |
| 6 | Derivative | Share Option (Right to Buy) | 2026-03-11 | M | D | 1,274 | $0.00 | 110,396 | D | $12.23 · — to 2034-06-04 | 1,274 Ordinary Shares | (F3) The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. (F6) These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. |
| 7 | Derivative | Share Option (Right to Buy) | 2026-03-11 | M | D | 1,430 | $0.00 | 22,490 | D | $14.96 · — to 2032-08-04 | 1,430 Ordinary Shares | (F3) The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. (F4) These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. |